- €115.78bn
- €129.18bn
- €44.29bn
- 92
- 45
- 75
- 86
REG - Stock Exch Notice - Admission to ISM - 14/02/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/09/2024
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/06/2024
AnnouncementRCS - Issuer Direct NEWCO - Ad Scientiam Launches Study to Assess MSCopilot
AnnouncementRCS - BioMed X Institute - BioMed X Researches Drug Development with Sanofi
AnnouncementRCS - Envision Pharma Grp - Envision Pharma Group Appoints Mike Glover to SVP
AnnouncementREG - Capital Group Co. Sanofi SA Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Capital Group Co. Amgen Inc. Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - BkofA Merrill Lynch - HORIZON THERAPEUTICS PLC_38.5 (b)_IE
AnnouncementREG - BkofA Merrill Lynch - HORIZON THERAPEUTICS PLC_38.5 (b)_IE
AnnouncementREG - Goldman Sachs (EPT) - Form 38.5b - Horizon Therapeutics plc
AnnouncementREG - Goldman Sachs & Co. - Form 38.5b - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch - HORIZON THERAPEUTICS PLC_38.5 (b)_IE
AnnouncementREG - Goldman Sachs (EPT) - Form 38.5b - Horizon Therapeutics plc
AnnouncementREG - Goldman Sachs & Co. - Form 38.5b - Horizon Therapeutics plc
AnnouncementREG - Capital Group Co. Amgen Inc. Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - BkofA Merrill Lynch - HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - Goldman Sachs (EPT) - Form 38.5b - Horizon Therapeutics plc
AnnouncementREG - Capital Group Co. Amgen Inc. Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
Announcement